共 50 条
- [1] Updated results from CARTITUDE-1: Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T (CAR-T) cell therapy, in relapsed/refractory multiple myeloma (RRMM)CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S15 - S16Jagannath, SundarBerdeja, Jesus G.Jakubowiak, AndrzejAgha, MounzerCohen, AdamMadduri, DeepuHari, ParameswaranYeh, Tzu-MinOlyslager, YunsiBanerjee, ArnobJackson, Carolyn C.Allred, AliciaZudaire, EnriqueDeraedt, WilliamWu, XiaolingPacaud, LidaAkram, MuhammadLin, YiMartin, ThomasUsmani, Saad Z.
- [2] Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study (vol 398, pg 314, 2021)LANCET, 2021, 398 (10307): : 1216 - 1216Berdeja, J. G.Madduri, D.Usmani, S. Z.
- [3] Ciltacabtagene autoleucel, a B-cell maturation antigendirected chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label studyLANCET, 2021, 398 (10297): : 314 - 324Berdeja, Jesus G.Madduri, DeepuUsmani, Saad Z.Jakubowiak, AndrzejAgha, MounzerCohen, Adam D.Stewart, A. KeithHari, ParameswaranHtut, MyoLesokhin, AlexanderDeol, AbhinavMunshi, Nikhil C.O'Donnell, ElizabethAvigan, DavidSingh, IndrajeetZudaire, EnriqueYeh, Tzu-MinAllred, Alicia J.Olyslager, YunsiBanerjee, ArnobJackson, Carolyn C.Goldberg, Jenna D.Schecter, Jordan M.Deraedt, WilliamZhuang, Sen HongInfante, JeffreyGeng, DongWu, XiaolingCarrasco-Alfonso, Marlene J.Akram, MuhammadHossain, FarahRizvi, SyedFan, FrankLin, YiMartin, ThomasJagannath, Sundar
- [4] Updated Results from CARTITUDE-1: Phase 1b/2Study of Ciltacabtagene Autoleucel, a B-Cell Maturation AntigenDirected Chimeric Antigen Receptor T Cell Therapy, in Patients With Relapsed/Refractory Multiple MyelomaBLOOD, 2021, 138Martin, ThomasUsmani, Saad Z.Berdeja, Jesus G.Jakubowiak, AndrzejAgha, MounzerCohen, Adam D.Hari, ParameswaranAvigan, DavidDeol, AbhinavHtut, MyoLesokhin, AlexanderMunshi, Nikhil C.O'Donnell, ElizabethStewart, A. KeithSchecter, Jordan M.Goldberg, Jenna D.Jackson, Carolyn C.Yeh, Tzu-MinBanerjee, ArnobAllred, AliciaZudaire, EnriqueDeraedt, WilliamMadduri, DeepuOlyslager, YunsiZhou, ChangweiPacaud, LidaLin, YiJagannath, Sundar
- [5] CARTITUDE-1: Phase 1b/2 study of ciltacabtagene autoleucel in relapsed/Refractory multiple myelomaBRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 16 - 17Madduri, DeepuBerdeja, JesusUsmani, SaadJakubowiak, AndrzejAgha, MounzerCohen, AdamStewart, A. KeithHari, ParameswaranHtut, MyoO'Donnell, ElizabethMunshi, NikhilAvigan, DavidDeol, AbhinavLesokhin, AlexanderSingh, IndrajeetZudaire, EnriqueYeh, Tzu-MinAllred, AliciaOlyslager, YunsiBanerjee, ArnobGoldberg, JennaSchecter, JordanJackson, CarolynDeraedt, WilliamZhuang, Sen HongInfante, JeffreyGeng, DongWu, XiaolingCarrasco-Alfonso, MarleneAkram, MuhammadHossain, FarahRizvi, SyedFan, FrankJagannath, SundarLin, YiMartin, Thomas
- [6] Ciltacabtagene Autoleucel, an Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-UpJOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (06) : 1265 - +Martin, ThomasUsmani, Saad Z.Berdeja, Jesus G.Agha, MounzerCohen, Adam D.Hari, ParameswaranAvigan, DavidDeol, AbhinavHtut, MyoLesokhin, AlexanderMunshi, Nikhil C.O'Donnell, ElizabethStewart, A. KeithSchecter, Jordan M.Goldberg, Jenna D.Jackson, Carolyn C.Yeh, Tzu-MinBanerjee, ArnobAllred, AliciaZudaire, EnriqueDeraedt, WilliamOlyslager, YunsiZhou, ChangweiPacaud, LidaMadduri, DeepuJakubowiak, AndrzejLin, YiJagannath, Sundar
- [7] CARTITUDE-1: Two-Year Post Last Patient in (LPI) Results From the Phase 1b/2 Study of Ciltacabtagene Autoleucel (Cilta-Cel), a B-Cell Maturation Antigen (BCMA)-Directed Chimeric Antigen Receptor T (CAR-T) Cell Therapy, in Patients With Relapsed/Refractory Multiple Myeloma (RRMM)CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S410 - S411Usmani, Saad Z.Martin, ThomasBerdeja, Jesus G.Jakubowiak, AndrzejAgha, MounzerCohen, Adam D.Deol, AbhinavHtut, MyoLesokhin, AlexanderMunshi, Nikhil C.O'Donnell, ElizabethJackson, Carolyn C.Yeh, Tzu-minBanerjee, ArnobZudaire, EnriqueMadduri, DeepuZhou, ChangweiPacaud, LidaLin, YiJagannath, Sundar
- [8] Patient Expectations and Perceptions of Treatment in CARTITUDE-1: Phase 1b/2 Study of Ciltacabtagene Autoleucel in Relapsed/Refractory Multiple MyelomaBLOOD, 2020, 136Cohen, Adam D.Hari, ParameswaranHtut, MyoBerdeja, Jesus G.Madduri, DeepuUsmani, Saad Z.Allred, Alicia J.Olyslager, YunsiBanerjee, ArnobGoldberg, Jenna D.Schecter, Jordan M.Jackson, Carolyn C.Gries, Katharine S.Fastenau, JohnDeraedt, WilliamCarrasco, Marlene J.Akram, MuhammadHossain, FarahCrawford, SigridMorrison, RossDoward, LyndaJakubowiak, Andrzej
- [9] Ciltacabtagene autoleucel, a B-cell maturation antigen (BCMA)-directed chimeric antigen receptor T-cell (CAR-T) therapy, in relapsed/refractory multiple myeloma (R/R MM): Updated results from CARTITUDE-1.JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)Usmani, Saad ZafarBerdeja, Jesus G.Madduri, DeepuJakubowiak, Andrzej J.Agha, Mounzer E.Cohen, Adam D.Hari, ParameswaranYeh, Tzu-MinOlyslager, YunsiBanerjee, ArnobJackson, Carolyn ChangAllred, Alicia JonesZudaire, EnriqueDeraedt, WilliamWu, XiaolingCarrasco-Alfonso, MarleneAkram, MuhammadLin, YiMartin, Thomas G.Jagannath, Sundar
- [10] SAFETY AND MANAGEMENT OF ADVERSE EVENTS WITH CILTACABTAGENE AUTOLEUCEL, A CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: INITIAL RESULTS FROM CARTITUDE-1ONCOLOGY NURSING FORUM, 2021, 48 (02)Florendo, ErikaWilmoth, JenaiRomanov, VadimGarrett, AhsrafMartin, ThomasMadduri, Deepu